Dopaminerge lægemidler til behandling af depression
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Dokumenter
- Fulltext
Forlagets udgivne version, 431 KB, PDF-dokument
A significant proportion of patients with depression do not respond to classic antidepressants addressing serotonergic or noradrenergic neurotransmission. Certain clinical features of depression seem to involve dopaminergic neurotransmission. Although medications with specific dopaminergic actions are used in the treatment of depression in other countries (e.g. the United States), these drugs are rarely mentioned in Danish treatment guidelines. This review aims at comprehending current dopaminergic treatment strategies and future directions in this field.
Bidragets oversatte titel | Dopaminergic drugs in the treatment of depression |
---|---|
Originalsprog | Dansk |
Tidsskrift | Ugeskrift for Laeger |
Vol/bind | 183 |
Udgave nummer | 47 |
Antal sider | 7 |
ISSN | 0041-5782 |
Status | Udgivet - 22 nov. 2021 |
- Antidepressive Agents/therapeutic use, Depression/drug therapy, Dopamine, Dopamine Agents, Humans, Norepinephrine
Forskningsområder
Links
- https://content.ugeskriftet.dk/sites/default/files/scientific_article_files/2021-11/v06210490_web.pdf
Forlagets udgivne version
ID: 305549600